Pharmacy's Compounding Resembles Rx Manufacturing Operation, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA "warning letter" states that Lincare and Reliant Pharmacy produce "essentially copies of commercially available drugs" without documented patient-specific medical need. This practice goes beyond the scope of traditional compounding, the letter states.